Cargando…

Spontaneous Tumor Lysis Syndrome Due to Endometrial Carcinoma

Spontaneous tumor lysis syndrome (TLS) is a rare condition in solid tumors, particularly in endometrial carcinoma. Spontaneous TLS occurs without the use of cytotoxic therapy but is observed particularly in hematologic malignancies. Given the high morbidity and mortality associated with spontaneous...

Descripción completa

Detalles Bibliográficos
Autores principales: Chango Azanza, Juan Jose, Mathew Thomas, Vinay, Calle Sarmiento, Paola Michelle, Singh, Meghana, Alexander, Swetha Ann
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7141803/
https://www.ncbi.nlm.nih.gov/pubmed/32274278
http://dx.doi.org/10.7759/cureus.7220
_version_ 1783519261585571840
author Chango Azanza, Juan Jose
Mathew Thomas, Vinay
Calle Sarmiento, Paola Michelle
Singh, Meghana
Alexander, Swetha Ann
author_facet Chango Azanza, Juan Jose
Mathew Thomas, Vinay
Calle Sarmiento, Paola Michelle
Singh, Meghana
Alexander, Swetha Ann
author_sort Chango Azanza, Juan Jose
collection PubMed
description Spontaneous tumor lysis syndrome (TLS) is a rare condition in solid tumors, particularly in endometrial carcinoma. Spontaneous TLS occurs without the use of cytotoxic therapy but is observed particularly in hematologic malignancies. Given the high morbidity and mortality associated with spontaneous TLS, it is crucial to identify and treat it promptly. There have been only four cases of spontaneous TLS reported to date in the literature from a uterine source. We present a 59-year-old female with a recently diagnosed endometrial carcinoma with neuroendocrine features by dilation and curettage who presented to the hospital with somnolence, decreased oral intake, and lower abdominal pain of three days duration. She was found to have sepsis secondary to endometritis and spontaneous tumor lysis syndrome by clinical and laboratory definitions (hyperkalemia, hyperphosphatemia, hyperuricemia, and hypocalcemia). Signs of disease progression were found such as worsening retroperitoneal lymphadenopathy that corresponded with the suspected increased tumoral activity. We report the case of a solid tumor (endometrial) presenting with spontaneous TLS, which highlights the importance of the early identification and initiation of treatment.
format Online
Article
Text
id pubmed-7141803
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-71418032020-04-09 Spontaneous Tumor Lysis Syndrome Due to Endometrial Carcinoma Chango Azanza, Juan Jose Mathew Thomas, Vinay Calle Sarmiento, Paola Michelle Singh, Meghana Alexander, Swetha Ann Cureus Internal Medicine Spontaneous tumor lysis syndrome (TLS) is a rare condition in solid tumors, particularly in endometrial carcinoma. Spontaneous TLS occurs without the use of cytotoxic therapy but is observed particularly in hematologic malignancies. Given the high morbidity and mortality associated with spontaneous TLS, it is crucial to identify and treat it promptly. There have been only four cases of spontaneous TLS reported to date in the literature from a uterine source. We present a 59-year-old female with a recently diagnosed endometrial carcinoma with neuroendocrine features by dilation and curettage who presented to the hospital with somnolence, decreased oral intake, and lower abdominal pain of three days duration. She was found to have sepsis secondary to endometritis and spontaneous tumor lysis syndrome by clinical and laboratory definitions (hyperkalemia, hyperphosphatemia, hyperuricemia, and hypocalcemia). Signs of disease progression were found such as worsening retroperitoneal lymphadenopathy that corresponded with the suspected increased tumoral activity. We report the case of a solid tumor (endometrial) presenting with spontaneous TLS, which highlights the importance of the early identification and initiation of treatment. Cureus 2020-03-09 /pmc/articles/PMC7141803/ /pubmed/32274278 http://dx.doi.org/10.7759/cureus.7220 Text en Copyright © 2020, Chango Azanza et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Internal Medicine
Chango Azanza, Juan Jose
Mathew Thomas, Vinay
Calle Sarmiento, Paola Michelle
Singh, Meghana
Alexander, Swetha Ann
Spontaneous Tumor Lysis Syndrome Due to Endometrial Carcinoma
title Spontaneous Tumor Lysis Syndrome Due to Endometrial Carcinoma
title_full Spontaneous Tumor Lysis Syndrome Due to Endometrial Carcinoma
title_fullStr Spontaneous Tumor Lysis Syndrome Due to Endometrial Carcinoma
title_full_unstemmed Spontaneous Tumor Lysis Syndrome Due to Endometrial Carcinoma
title_short Spontaneous Tumor Lysis Syndrome Due to Endometrial Carcinoma
title_sort spontaneous tumor lysis syndrome due to endometrial carcinoma
topic Internal Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7141803/
https://www.ncbi.nlm.nih.gov/pubmed/32274278
http://dx.doi.org/10.7759/cureus.7220
work_keys_str_mv AT changoazanzajuanjose spontaneoustumorlysissyndromeduetoendometrialcarcinoma
AT mathewthomasvinay spontaneoustumorlysissyndromeduetoendometrialcarcinoma
AT callesarmientopaolamichelle spontaneoustumorlysissyndromeduetoendometrialcarcinoma
AT singhmeghana spontaneoustumorlysissyndromeduetoendometrialcarcinoma
AT alexanderswethaann spontaneoustumorlysissyndromeduetoendometrialcarcinoma